% IMPORTANT: The following is UTF-8 encoded. This means that in the presence
% of non-ASCII characters, it will not work with BibTeX 0.99 or older.
% Instead, you should use an up-to-date BibTeX implementation like “bibtex8” or
% “biber”.
@ARTICLE{Klose:273940,
author = {Klose, Veronika and Jesse, Sarah and Lewerenz, Jan and
Kassubek, Jan and Dorst, Johannes and Rosenbohm, Angela and
Nagel, Gabriele and Wernecke, Deborah and Roselli, Francesco
and Tumani, Hayrettin and Ludolph, Albert C},
title = {{B}lood-{CSF} barrier integrity in amyotrophic lateral
sclerosis.},
journal = {Brain},
volume = {147},
number = {12},
issn = {0006-8950},
address = {Oxford},
publisher = {Oxford Univ. Press},
reportid = {DZNE-2024-01414},
pages = {4254 - 4264},
year = {2024},
abstract = {The integrity of the blood-CSF barrier plays a major role
in inflammation, but also in shielding the CNS from external
and systemic-potentially toxic-factors. Here we report
results of measurements of the albumin quotient-which is
thought to mirror the integrity of the blood-CSF barrier-in
1059 patients with amyotrophic lateral sclerosis. The
results were compared with groups of patients suffering from
Alzheimer's disease, facial palsy and tension headache. The
albumin quotient, an accepted measure of the blood-CSF
barrier integrity, was not significantly different from
control populations. In addition, we found that the albumin
quotient correlated with survival of the patients; this
effect was mainly driven by male patients and influenced by
age, body mass index and diabetes mellitus. We conclude that
the blood-CSF barrier is intact in this large cohort of
patients with amyotrophic lateral sclerosis and that the
albumin quotient correlates with survival. Whether this is
important for the pathogenesis of the disease, requires
mechanistic studies.},
keywords = {Humans / Amyotrophic Lateral Sclerosis / Male / Female /
Middle Aged / Aged / Blood-Brain Barrier: metabolism / Adult
/ Albumins: metabolism / Aged, 80 and over / Cohort Studies
/ albumin quotient (Other) / amyotrophic lateral sclerosis
(Other) / blood-CSF barrier (Other) / cerebrospinal fluid
(Other) / survival (Other) / Albumins (NLM Chemicals)},
cin = {Clinical Study Center (Ulm) / AG Zhan / AG Roselli},
ddc = {610},
cid = {I:(DE-2719)5000077 / I:(DE-2719)1910005 /
I:(DE-2719)1910001},
pnm = {353 - Clinical and Health Care Research (POF4-353) / 354 -
Disease Prevention and Healthy Aging (POF4-354) / 352 -
Disease Mechanisms (POF4-352)},
pid = {G:(DE-HGF)POF4-353 / G:(DE-HGF)POF4-354 /
G:(DE-HGF)POF4-352},
typ = {PUB:(DE-HGF)16},
pubmed = {pmid:38743595},
doi = {10.1093/brain/awae144},
url = {https://pub.dzne.de/record/273940},
}